Progyny Inc <PGNY.O>: Leerink Partners Raises Target Price to $38 From $30
PGNY•Related News
Evogene, ELEO collaborate to develop oral small-molecule PCSK9 inhibitors for hyperlipidemia
EVGN•
OFS Capital updates financial calendar with second-quarter earnings release, conference call
OFS•
Prologis makes final eleventh-hour $18.8 billion takeover bid for UK's Segro
PLD•
BlackRock voting rights in Metso fall to 5.6%
BLK•
Shipping firm High-Trend International's H1 revenue rises on dry bulk demand
HTCO•